Eliem Therapeutics Stock Value 2021-2024

Interactive chart of historical stock value for Eliem Therapeutics over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Eliem Therapeutics market value as of October 03, 2024 is $0.34B.
Eliem Therapeutics Annual Market Value
Eliem Therapeutics Quarterly Market Value
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.342B $0.000B
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
Stock Name Country Market Cap PE Ratio
Chesapeake Energy (EXE) United States $11.186B 28.69
Hammerson (HMSND) United Kingdom $2.121B 0.00
American Software (LGTY) United States $0.388B 29.97
Learn CW Investment (INV) United States $0.204B 0.00
Nicholas Financial (OMCC) United States $0.079B 0.00
ExcelFin Acquisition (BDMD) $0.033B 0.00
Caravelle Group (HTCO) Singapore $0.024B 0.00
Recruiter (NIXX) United States $0.007B 0.00